Table 1.
Main characteristics of studies included in the meta-analysis.
| Study/year | Country | Genotypingmethod | Case | Control | Case |
Control |
HWE | ||||||||
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| GG | GA | AA | G | A | GG | GA | AA | G | A | ||||||
| Aftabi et al. 2017 | Iran | PCR-RFLP | 135 | 130 | 68 | 62 | 5 | 198 | 72 | 73 | 53 | 4 | 199 | 61 | 0.120 |
| Gu et al. 2011 | China | TaqMan | 567 | 573 | 255 | 231 | 81 | 741 | 393 | 249 | 244 | 80 | 742 | 404 | 0.108 |
| Liu et al. 2016 | China | PCR | 136 | 456 | 58 | 57 | 18 | 173 | 93 | 193 | 206 | 55 | 592 | 316 | 0.998 |
| Merisalu et al. 2007 | Estonia | ASPCR | 110 | 211 | 96 | 14 | 0 | 206 | 14 | 175 | 36 | 0 | 386 | 36 | 0.195 |
| Mostafa et al. 2017 | Egypt | Real-time PCR | 120 | 50 | 43 | 21 | 56 | 107 | 133 | 28 | 15 | 7 | 71 | 29 | 0.055 |
| Safarinejad et al. 2013 | Iran | PCR | 176 | 352 | 73 | 89 | 14 | 235 | 117 | 131 | 152 | 69 | 414 | 290 | 0.710 |
| Watanabe et al. 2004 | Japan | PCR | 123 | 112 | 36 | 64 | 23 | 136 | 110 | 32 | 58 | 22 | 122 | 102 | 0.641 |